Save The Date

Nashville
Hematology
Conference

February 26-28, 2026

2-Day CE-Accredited Conference  

at the Country Music Hall of Fame® and Museum

NASHVILLE, TN

Accreditation by

Presented by

#NashvilleHeme25

Conference Chairs

Drs. Jesús Berdeja, Director of Multiple Myeloma Research at Greco-Hainsworth Tennessee Oncology Centers for Research and Joanna Rhodes, Director of Lymphoma Program at Rutgers Cancer Institute of New Jersey invite you to join them at the inaugural 2-day CE accredited conference Nashville Hematology Conference in Tennessee.

Joanna Rhodes, MD, MSCE

Rutgers Cancer Institute of New Jersey

Jesús Berdeja, MD

Greco-Hainsworth Tennessee Oncology Centers for Research

Accreditation by

Presented by

About NHC 2025

CE Accredited Conference

Learning Objectives

  1. Discuss optimal evidence-based management of patients with hematologic malignancies across treatment settings.
  2. Share best practices in incorporating T-cell redirecting therapies into practice with particular focus on managing acute and long-term potential toxicities.
  3. Apply current prognostic testing to everyday practice across hematologic malignancies and throughout the patient journey.
  4. Recognize challenges of treating hematologic malignancies in patients with unmet needs in the community setting including frail patients and disparate populations.

For more information on sponsorship opportunities, please submit this form:

Sponsor &
Exhibit
Opportunities

Mark Your Calendar!

#NashvilleHeme25 starts in . .. ...

Days
Hours
Minutes